Pluristem Therapeutics Inc (PSTI)

[zzaatt]

I think it's very encouraging to see Pluristem proceed with the clinical work. It does seem to indicated that they've seen nothing to discourage them from proceeding. This is good, given the doubt created by the very slow progress in Covid testing.

It's also interesting to speculate that even as other therapeutics are coming on line, the PLX cell's more natural and specific "as needed" response may be superior in the long run. "Titrate to need" on a cellular and molecular level is something that monocloal antibodies cannot do.